CVS Health Reports Fourth Quarter And Full-Year 2020 Results And Provides 2021 Full Year Guidance

Go back to CVS Health Reports Fourth Quarter And Full-Year 2020 Results And Provides 2021 Full Year Guidance

CVS Health (CVS) Tops Q4 EPS by 6c, Offers FY Guidance

February 16, 2021 6:33 AM EST

CVS Health (NYSE: CVS) reported Q4 EPS of $1.30, $0.06 better than the analyst estimate of $1.24. Revenue for the quarter came in at $69.55 billion versus the consensus estimate of $68.73 billion.

GUIDANCE:

CVS Health sees FY2021 EPS of $7.39-$7.55, versus the consensus of... More